Exercise, inflammation, and fatigue in cancer survivors

Authors

  • Emily C. P. LaVoy Laboratory of Integrated Physiology, Department of Health and Human Performance, University of Houston, Houston, TX, USA Author
  • Christopher P. Fagundes Department of Psychology, Rice University, Houston, TX, USA Author
  • Robert Dantzer Department of Symptom Research, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA Author

DOI:

https://doi.org/10.22029/eir.2016.1710

Keywords:

HEART-RATE-VARIABILITY, QUALITY-OF-LIFE, RANDOMIZED CONTROLLED-TRIAL, DIURNAL CORTISOL RHYTHM, BREAST-CANCER, PHYSICAL-ACTIVITY, LONG-TERM, AUTONOMIC DYSFUNCTION, CHANGE INTERVENTION, MULTIPLE-SCLEROSIS

Abstract

Cancer-related fatigue significantly disrupts normal functioning and quality of life for a substantial portion of cancer survivors, and may persist for years following cancer treatment. While the causes of persistent fatigue among cancer survivors are not yet fully understood, accumulating evidence suggests that several pathways, including chronic inflammation, autonomic imbalance, HPA-axis dysfunction, and/or mitochondrial damage, could contribute towards the disruption of normal neuronal function and result in the symptom of cancer-related fatigue. Exercise training interventions have been shown to be some of the more successful treatment options to address cancer-related fatigue. In this review, we discuss the literature regarding the causes of persistent fatigue in cancer survivors and the mechanisms by which exercise may relieve this symptom. There is still much work to be done until the prescription of exercise becomes standard practice for cancer survivors. With improvements in the quality of studies, evidenced-based exercise interventions will allow exercise scientists and oncologists to work together to treat cancer-related fatigue.

References

Downloads

Published

2016-12-31

Issue

Section

Articles